Mips Logo

Mips

Specializes in helmet-based safety technology to redirect rotational motion.

MIPS | ST

Overview

Corporate Details

ISIN(s):
SE0009216278 (+4 more)
LEI:
549300LZSA4S0L54VQ25
Country:
Sweden
Address:
Kemistvägen 1B, 183 79 TÄBY

Description

Mips is a company specializing in helmet-based safety technology. Its primary product is the Mips® Safety System (Multi-directional Impact Protection System), a technology integrated into helmets by various manufacturers. The system features a low-friction layer that allows for a slight, multi-directional movement (10-15mm) of the helmet relative to the head during an angled impact. This movement is designed to redirect potentially harmful rotational motion away from the brain, which is a common cause of brain injury in oblique impacts. Developed through extensive biomechanical research by a brain surgeon and a scientist, the Mips system is licensed to helmet brands and incorporated into products for a wide range of activities, including cycling, snow sports, motorsports, equestrian sports, and construction.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 23:50
Mips acquires Koroyd, strengthening world-leading helmet safety technology port…
English 45.9 KB
2025-12-11 23:50
Mips förvärvar Koroyd och stärker sin världsledande portfölj inom hjälmsäkerhet…
Swedish 46.2 KB
2025-10-22 07:30 Swedish 2.2 MB
2025-10-22 07:30 English 2.2 MB
2025-07-16 07:30 Swedish 1.9 MB
2025-07-16 07:30 English 1.9 MB
2025-05-07 11:45
Kommuniké från årsstämman i Mips AB (publ) den 7 maj 2025
Swedish 36.0 KB
2025-05-07 11:45
Press release from the Annual General Meeting in Mips AB (publ) on 7 May 2025
English 33.4 KB
2025-04-24 07:30 Swedish 1.2 MB
2025-04-24 07:30 English 1.2 MB
2025-04-02 08:00
Notice to the Annual General Meeting of Mips AB (publ)
English 73.4 KB
2025-03-20 17:20 Swedish 2.5 MB
2025-02-05 18:10
Mips updates long-term financial target
English 39.4 KB
2025-02-05 18:10
Mips uppdaterar långsiktigt finansiellt mål
Swedish 39.3 KB
2025-02-05 18:10 Swedish 3.0 MB

Automate Your Workflow. Get a real-time feed of all Mips filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mips

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mips via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-25 Thomas Bräutigam Other Sell 4,500 2,430,000.00 SEK
2023-09-14 John Fredrik Kjellberg Other Sell 10,300 3,705,837.00 SEK
2023-03-03 Maria Hedengren Other Buy 200 98,254.00 SEK
2022-10-18 Thomas Bräutigam Other Buy 2,000 609,594.40 SEK
2022-10-17 Thomas Bräutigam Other Buy 3,000 907,927.80 SEK
2022-05-06 Thomas Bräutigam Other Buy 1,000 580,600.00 SEK
2022-05-05 Thomas Bräutigam Other Buy 2,000 1,253,200.00 SEK
2022-03-07 Jonas Rahmn Other Buy 107 75,301.25 SEK
2022-03-07 Jonas Rahmn Other Buy 94 66,317.00 SEK
2022-03-07 Jonas Rahmn Other Buy 90 63,495.00 SEK

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.